These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22726930)

  • 1. Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position.
    Hamada Y; Nakanishi T; Suzuki K; Yamaguchi R; Hamada T; Hidaka K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4640-4. PubMed ID: 22726930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of interactions of BACE1-Arg235 with its ligands and design of BACE1 inhibitors with P2 pyridine scaffold.
    Hamada Y; Ohta H; Miyamoto N; Sarma D; Hamada T; Nakanishi T; Yamasaki M; Yamani A; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2009 May; 19(9):2435-9. PubMed ID: 19345096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position.
    Hamada Y; Suzuki K; Nakanishi T; Sarma D; Ohta H; Yamaguchi R; Yamasaki M; Hidaka K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2014 Jan; 24(2):618-23. PubMed ID: 24360554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel non-peptidic and small-sized BACE1 inhibitors.
    Hamada Y; Ohta H; Miyamoto N; Yamaguchi R; Yamani A; Hidaka K; Kimura T; Saito K; Hayashi Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1643-7. PubMed ID: 18261904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.
    Hamada Y; Tagad HD; Nishimura Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1130-5. PubMed ID: 22178553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
    Tagad HD; Hamada Y; Nguyen JT; Hamada T; Abdel-Rahman H; Yamani A; Nagamine A; Ikari H; Igawa N; Hidaka K; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2010 May; 18(9):3175-86. PubMed ID: 20381362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BACE1 inhibitors: optimization by replacing the P1' residue with non-acidic moiety.
    Hamada Y; Abdel-Rahman H; Yamani A; Nguyen JT; Stochaj M; Hidaka K; Kimura T; Hayashi Y; Saito K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1649-53. PubMed ID: 18249539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.
    Suzuki K; Hamada Y; Nguyen JT; Kiso Y
    Bioorg Med Chem; 2013 Nov; 21(21):6665-73. PubMed ID: 23993670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine.
    Kimura T; Shuto D; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Hattori C; Asai M; Kitazume S; Saido TC; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2004 Mar; 14(6):1527-31. PubMed ID: 15006396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio)butyric acid.
    Ziora Z; Kasai S; Hidaka K; Nagamine A; Kimura T; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1629-33. PubMed ID: 17251016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACE1 Inhibitor Peptides: Can an Infinitely Small k cat Value Turn the Substrate of an Enzyme into Its Inhibitor?
    Hamada Y; Ishiura S; Kiso Y
    ACS Med Chem Lett; 2012 Mar; 3(3):193-7. PubMed ID: 24900449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors.
    Cumming JN; Le TX; Babu S; Carroll C; Chen X; Favreau L; Gaspari P; Guo T; Hobbs DW; Huang Y; Iserloh U; Kennedy ME; Kuvelkar R; Li G; Lowrie J; McHugh NA; Ozgur L; Pan J; Parker EM; Saionz K; Stamford AW; Strickland C; Tadesse D; Voigt J; Wang L; Wu Y; Zhang L; Zhang Q
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3236-41. PubMed ID: 18468890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From fragment screening to in vivo efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1).
    Cheng Y; Judd TC; Bartberger MD; Brown J; Chen K; Fremeau RT; Hickman D; Hitchcock SA; Jordan B; Li V; Lopez P; Louie SW; Luo Y; Michelsen K; Nixey T; Powers TS; Rattan C; Sickmier EA; St Jean DJ; Wahl RC; Wen PH; Wood S
    J Med Chem; 2011 Aug; 54(16):5836-57. PubMed ID: 21707077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of potent BACE-1 inhibitors incorporating a hydroxyethylene isostere as central core.
    Wångsell F; Gustafsson K; Kvarnström I; Borkakoti N; Edlund M; Jansson K; Lindberg J; Hallberg A; Rosenquist A; Samuelsson B
    Eur J Med Chem; 2010 Mar; 45(3):870-82. PubMed ID: 20036448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment-based discovery and optimization of BACE1 inhibitors.
    Madden J; Dod JR; Godemann R; Kraemer J; Smith M; Biniszkiewicz M; Hallett DJ; Barker J; Dyekjaer JD; Hesterkamp T
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5329-33. PubMed ID: 20656487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro biological evaluation and molecular docking studies of benzimidamides as potential BACE1 inhibitors.
    Niu Y; Gao H; Xu F; Wang C; Liu P; Yang G; Sun Q; Xu P
    Chem Biol Drug Des; 2012 Nov; 80(5):775-80. PubMed ID: 22882897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.